The global production of Abacavir Sulfate Active Pharmaceutical Ingredient (API) is handled by a relatively small number of focused manufacturers. Several firms across regions like Europe and the US hold significant percentages in this critical segment of the pharmaceutical arena. Purity is of the utmost importance, necessitating stringent regulato